foberigan   Click here for help

GtoPdb Ligand ID: 14629

Synonyms: compound C112 [US11453690] | TDI05 | TRD205
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Foberigan is the INN for an angiotensin II type 2 (AT2) receptor antagonist that was included in WHO INN Proposed List 135 (July 2026). It is one of the structures claimed in patents held by Beijing Tide Pharmaceutical [2]. The structure of Beijing Tide's lead AT2 antagonist TRD205/TDI05 [1] is identical to that assigned to foberigan.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 84.4
Molecular weight 498.57
XLogP 1.8
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CC1=CC=CC=C1)C(=O)N2[C@@]3([H])CC[C@]2([H])[C@@H](C(=O)O)N(C3)C(=O)N(C4=CC=CC=C4)C5=CC=CC=C5
Isomeric SMILES C(N(CC1=CC=CC=C1)C)(=O)N2[C@]3([C@@H](C(O)=O)N(C(N(C4=CC=CC=C4)C5=CC=CC=C5)=O)C[C@@]2(CC3)[H])[H]
InChI InChI=1S/C29H30N4O4/c1-30(19-21-11-5-2-6-12-21)28(36)33-24-17-18-25(33)26(27(34)35)31(20-24)29(37)32(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26H,17-20H2,1H3,(H,34,35)/t24-,25+,26-/m0/s1
InChI Key SAGCINJDOCNPSJ-NXCFDTQHSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
TRD205/TDI05 is a clinical candidate for the treatment of neuropathic pain.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT07543796 Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb) Phase 2 Interventional Beijing Tide Pharmaceutical Co., Ltd
NCT07123402 To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia Phase 2 Interventional Beijing Tide Pharmaceutical Co., Ltd
NCT07121101 To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty Phase 2 Interventional Beijing Tide Pharmaceutical Co., Ltd